SurroMed, Relocating to PPD s Digs, Trades Stock for Cancer Markers

genomeweb
360dx

SurroMed, Relocating to PPD s Digs, Trades Stock for Cancer Markers

Jul 17, 2003

Click here for an updated version of this story.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Genome-Wide Analysis More Than Doubles Loci Linked to Osteoarthritis Risk
NantHealth Receives Nasdaq Delisting Notice
People in the News: TJ Johnson, Deanna Church, Jonathan Jaglom, More
In Brief This Week: All of Us Research Program, Cancer Genetics, Precipio, and More
Biocept Prices $2.2M Registered Direct Offering
New Products Posted to GenomeWeb: Oxford Nanopore, NRGene, Macrogen, HTG Molecular

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Main menu